PReS-FINAL-2224: Canakinumab treatment regimens in CAPS-patients [PDF]
, 2013 F Hofer +10 more
openalex +1 more source
OP0272 LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH COLCHICINE-RESISTANT FAMILIAL MEDITERRANEAN FEVER: RESULTS FROM THE RANDOMISED PHASE 3 CLUSTER TRIAL [PDF]
, 2020 Seza Özen +10 more
openalex +1 more source
Interleukin-1 beta inhibition with canakinumab and reducing lung cancer—subset analysis of the canakinumab anti-inflammatory thrombosis outcome study trial (CANTOS) [PDF]
, 2018 David C. Crossman, Alexander Rothman
openalex +1 more source
A Case of Hyperimmunoglobulinemia D Syndrome Successfully Treated with Canakinumab [PDF]
, 2013 Elena Tsitsami +2 more
openalex +1 more source
, 2023 Marco Gattorno +8 more
openalex +1 more source
Neurological outcome of patients with cryopyrin-associated periodic syndrome (CAPS) [PDF]
, 2017 core +1 more source
A 51-Year Old Woman with Schnitzler Syndrome Treated with Canakinumab [PDF]
, 2011 Simon Francis Thomsen +2 more
openalex +1 more source
Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial [PDF]
, 2020 Claudia Kedor +12 more
openalex +1 more source
Use of canakinumab and remdesivir in moderate-severe COVID-19 patients: A retrospective analysis [PDF]
, 2023 Antonio Mastroianni +8 more
openalex +1 more source
Infectious adverse effects during treatment with IL-1 inhibitors in patients with systemic juvenile idiopathic arthritis and autoinflammatory diseases [PDF]
, 2014 core +1 more source